We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Warns Texas Compounder for Adulterated Drugs
Serious deficiencies in sterile drug production at Greenpark Compounding in Houston, Texas, may put patients at risk, the FDA said in a warning letter to the compounder.